CRISPR/Cas9 Genome-edited Cells Express NanoBRET-donor that Monitors Protein Interaction and Trafficking
19 January 2018

G protein-coupled receptors are important drug targets requiring receptor-protein interaction and trafficking studies to reveal how they function. This report shows how CRISPR/Cas9 genome editing enables the study of such interactions and trafficking.